Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 266,960 | 257,244 | 211,042 | 326,551 | 475,824 |
| Cost of Goods | 117,553 | 158,992 | 70,083 | 57,591 | 37,667 |
| Gross Profit | 149,407 | 98,252 | 140,959 | 268,960 | 438,157 |
| Operating Expenses | 261,627 | 302,443 | 397,922 | 533,409 | 282,505 |
| Operating Income | -111,667 | -203,199 | -256,880 | -263,858 | 156,319 |
| Interest Expense | 27,158 | 40,542 | 32,474 | 22,959 | 21,166 |
| Other Income | 167,332 | 5,469 | -2,400 | -283 | 554 |
| Pre-tax Income | 28,507 | -238,272 | -291,754 | -287,100 | 135,707 |
| Income Tax | N/A | -380 | N/A | N/A | 3,463 |
| Net Income Continuous | 28,507 | -237,892 | -291,754 | -287,100 | 132,244 |
| Net Income | $28,507 | $-237,892 | $-291,754 | $-287,100 | $132,244 |
| EPS Basic Total Ops | 0.25 | -2.53 | -3.76 | -3.81 | 1.85 |
| EPS Basic Continuous Ops | 0.25 | -2.53 | -3.76 | -3.81 | 1.85 |
| EPS Diluted Total Ops | 0.25 | -2.53 | -3.76 | -3.81 | 1.62 |
| EPS Diluted Continuous Ops | 0.25 | -2.53 | -3.76 | -3.81 | 1.58 |
| EPS Diluted Before Non-Recurring Items | 0.25 | -2.43 | -3.68 | -3.81 | 1.62 |
| EBITDA(a) | $-106,391 | $-199,408 | $-253,181 | $-260,404 | $159,207 |